- 1 day ago
Post Treatment, Children With ALL Experience Long-Term Fatigue
Children experience symptoms of fatigue for at least 2 years following for acute lymphoblastic leukemia (ALL), according to a new study,...
- Apr 24
Besponsa ‘More Effective’ at Driving Remission for Pediatric B-ALL
Besponsa provides another — and potentially more effective — option outside of traditional chemotherapy for pediatric patients with...
- Apr 16
Researchers find genetic variant contributing to disparities in childhood leukemia risk
Acute lymphoblastic leukemia (ALL), the most common childhood cancer, disproportionately affects children of Hispanic/Latino origin in...
- Apr 2
What to Do if Your Child’s Leukemia Comes Back
About 15 percent of patients with ALL will relapse, while 30 to 50 percent of patients with AML will have a recurrence, says Melissa...
- Feb 14
Advancements in Treating Childhood B Cell Acute Lymphoblastic Leukemia: A Journey Towards Complete Remission
Childhood B cell acute lymphoblastic leukemia (B-ALL), a type of cancer that affects blood and bone marrow, has historically been a...
- Feb 8
‘We now know our enemy’: UBC study offers new hope for treating relapsed childhood leukemia
New therapies have dramatically improved survival rates among children with pediatric acute myeloid leukemia (pAML)—a cancer that starts...
- Feb 5
RNA sequencing analysis may hold the key to more accurate diagnosis and targeted treatment of pediatric B-acute lymphoblastic leukemia
Pilot study by Children’s Hospital Los Angeles and City of Hope proposes a promising global, clinically applicable genomic assay for the...
- Jan 29
Study finds concerning contributing factor to childhood cancer: ‘These findings have important public health implications’
Environmental Health News (EHN) reports that a recent large study published in the Journal of the National Cancer Institute links...